All Stories

  1. Targeting airway inflammation in cystic fibrosis

    Article • Expert Review of Respiratory Medicine, October 2019, Taylor & Francis

    Oliver McElvaney, Noel G McElvaney, Dr. Mark Murphy, Patricia Wade

  2. Emerging pharmacotherapies in cystic fibrosis

    Article • Expert Review of Respiratory Medicine, September 2018, Taylor & Francis

    Noel G McElvaney, oisin McElvaney, Oliver McElvaney

  3. The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals

    Article • Journal of Inflammation Research, March 2018, Dove Medical Press

    Noel G McElvaney

  4. An update on Alpha 1 antitrypsin deficiency

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2018, Dove Medical Press

    Professor Kenneth R Chapman, Rembert Koczulla, Noel G McElvaney

  5. Inhaled Hypertonic Saline as a Therapeutic Strategy to Dampen Inflammation in Cystic Fibrosis

    Article • Clinical Immunology Endocrine & Metabolic Drugs, August 2017, Bentham Science Publishers

    Noel G McElvaney, Oliver McElvaney

  6. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency

    Article • Annals of the American Thoracic Society, August 2016, American Thoracic Society

    Noel G McElvaney, Associate Professor Cormac McCarthy

  7. Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm

    Article • European Respiratory Review, February 2015, European Respiratory Society (ERS)

    Noel G McElvaney

  8. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema

    Article • Expert Review of Respiratory Medicine, January 2015, Taylor & Francis

    Noel G McElvaney, Associate Professor Cormac McCarthy

  9. Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

    Article • Therapeutics and Clinical Risk Management, January 2015, Taylor & Francis

    Noel G McElvaney

  10. Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis

    Article • Journal of Inflammation Research, January 2013, Taylor & Francis

    Noel G McElvaney

  11. The role of TIM-containing molecules in airway disease and their potential as therapeutic targets

    Article • Journal of Inflammation Research, August 2012, Taylor & Francis

    Noel G McElvaney

  12. Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency

    Article • Biologics Targets & Therapy, January 2009, Dove Medical Press

    Catherine Greene, Noel G McElvaney